EVIO Labs Massachusetts Applies for Recreational Testing License
Massachusetts law requires that all recreational marijuana products bear a seal showing they have been tested by a Commission-licensed independent laboratory for contaminants and potency levels.
American Osteopathic Association Declares Support for Review of Medical Cannabis
The American Osteopathic Association supports the reclassification of cannabis as a Schedule II Drug to facilitate advancement in clinical, public health, patient safety and health policy research, according to a resolution approved by the AOA House of Delegates.
Neuroprotective Cannabis Compounds May Help Treat Parkinson's Disease
Mounting evidence suggests that the inflammatory processes in the brain contribute to the pathologies of Parkinson's, Alzheimer's and HIV-Associated Neurocognitive Disorders.
Cannabinoids, the Heart of the Matter
Review claims that most people and many scientists are not aware of the potential uses for cannabinoids in treating cardiac hypertrophy and other heart diseases.
EVIO Labs Massachusetts Gains ISO/IEC 17025 Accreditation
Achieving ISO/IEC 17025 accreditation is the pinnacle in third-party laboratory accreditation.
Unique Cannabinoid Profile May Help Control Autoimmune Dysfunction in Multiple Sclerosis
A unique cannabis strain that has the capacity to inhibit dendritic-dependent T-cells proliferation has been identified by researchers in Israel.
CBD Bioavailability Enhanced by Novel Drug Delivery Technology
CBD delivered from Lexaria’s TurboCBDTM capsules was absorbed much more effectively than from the positive control, delivering 317% more CBD to blood at the 30-minute mark of the study.
ETCH Biotrace™Cannabis Tagging Technology Launched
Whether it is introduced at the cultivator, processor or manufacturer level, ETCH biotrace links a unique molecular tag to the cannabis plant that will survive conversion or extraction.
Cannabidiol Prevents Nausea in Rats
The cannabis-derived compound could be used to treat nausea in cancer patients receiving chemotherapy.
$9M Invested in Gauging the Long-term Effects of Cannabis on Adolescents
The grant will fund a series of preclinical studies to determine whether THC consumption during adolescence causes persistent neurological changes.
